The offering could increase float and pressure shares as existing holders sell a large block of stock.
LifeStance Health Group shareholders are selling 35 million shares in a secondary offering, aiming to raise capital through existing stake sales. The move follows recent market volatility and could dilute near-term share value for the behavioral health provider.
The offering size represents roughly 10% of the company’s outstanding shares, based on prior filings. Secondary sales often signal investor profit-taking or portfolio rebalancing, though terms of the deal remain undisclosed.
Shares may face downward pressure as the market absorbs the additional supply, though pricing details are pending.